美国公司增加了AstraZeneca的股份,AstraZeneca是一家领先的生物制药公司,市场上限为209.47B美元。 U.S. firms increase stakes in AstraZeneca, a leading biopharmaceutical company with a market cap of $209.47B.

美国投资公司Mariner LLC和Evergreen资本管理有限公司增加了其在生物制药公司AstraZeneca PLC的股份。 U.S. investment firms Mariner LLC and Evergreen Capital Management LLC have increased their holdings in biopharmaceutical company AstraZeneca PLC. Mariner LLC 的持股增加了 14.5%，而 Evergreen Capital Management LLC 的持股增加了 8.6%。 Mariner LLC's holdings rose by 14.5%, while Evergreen Capital Management LLC's increased by 8.6%. AstraZeneca侧重于处方药,市场资本为209.47亿美元。 AstraZeneca focuses on prescription medicines and has a market capitalization of $209.47 billion. 股票的“Buy”评级很高,目标价格为86.80美元。 The stock has a strong "Buy" rating and a target price of $86.80.